Fact CheckerSign in

NCT06893679Completed

Effects of Qigong Sensory Training on Sensory Modulation and Behavior in Children With Autism

Source: ClinicalTrials.gov · Last updated 2 Jan 2026

Brief summary (registry, in English)

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by challenges in social interaction, communication, and a range of repetitive behaviors. Among these challenges, sensory processing abnormalities are highly prevalent, manifesting as hyper- or hypo-sensitivity to sensory stimuli, and can significantly impact daily functioning and quality of life. In sensory modulation there are difficulties in regulating and responding appropriately to sensory input from the environment. Sensory modulation can have a significant impact on the daily lives of individuals with autism, affecting their ability to engage in various activities and navigate social interactions. Autistic children also have repetitive behaviors, such as repetitive actions like self-stimulation behavior, or stimming. These behaviors can involve one part of the body, the entire body or an object. QST in which deep pressure with thumb apply on head, neck, trunk and limbs along deep breathing which give relaxation to body and have effect on sensory modulation and behavior in children with Autism. The intended project aims to evaluate the sensory modulation and behavior in children with autism spectrum disorder (ASD) through Qigong Sensory Training (QST). A quasi-Experimental study will be conduct to evaluate the effect of QST on the sensory modulation and behavior of autistic children. 21 Participants will be included in the study with age of 4-12 years diagnosed with ASD. Participants will be received 15 mints massage therapy 2 times in a day and 5 days a week for 8 weeks. Before and after 8 week of intervention, Assessment of sensory modulation scale (ASMS) will be used to check the sensory modulation level and strength and difficulties questionnaire (SDQ) will be used to check the behavior. Data will be collected from Nishtar Hospital Multan. The pre and post intervention assessments will be done. The reliability and validity of tools are mentioned. The duration of study will be 10-months. Data will be analyzed with the help of SPSS 25.

Status (registry)
Completed
Study type
Interventional
Enrollment
26 (actual)
First submitted
19 Mar 2025
Start date
17 Mar 2025
Primary completion date
17 Aug 2025
Lead sponsor
Riphah International University
Diseases
Autism
NCT number
NCT06893679

What you commit to

  • Study type: Interventional
  • Participants enrolled: 26
  • From 17 Mar 2025 to the primary completion date, 17 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Children diagnosed with severe psychiatric conditions other than autism spectrum disorder (ASD), including but not limited to schizophrenia, bipolar disorder, and severe anxiety disorders.

Other

  • Children with severe physical disabilities that significantly impair their ability to participate in touch-based interventions, as determined by a qualified healthcare provider.

Who the study is looking for

  • Children aged 4 to12 years diagnosed with autism spectrum disorder.
  • Male and Female will be included in study.
  • Parental/guardian consent to participate in the study.
  • Children do not receive any other intervention therapy during study

Age in the registry: 4 years to 12 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Nishtar Medical University, Multan
Coordinator of this site? Confirm its status
Multan KhurdPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.